Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

FDA approves Gilead's potential hepatitis C blockbuster

Gilead Sciences Inc.'s big risk is paying off. The Foster City-based drug developer (NASDAQ: GILD) won Food and Drug Administration approval Friday for its potential blockbuster hepatitis C treatment, which will cost $84,000 for a 12-week course of treatment...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.